Poster HTX - Primary Graft Dysfunction

731 - Treatment with a Statin or Spironolactone is Associated with a Reduced Risk for Primary Graft Dysfunction and Mortality

Presentation Number
731
Speakers
Session Name
POSTER SESSION 1 - Heart Transplantation (Adult)
Date
Wed, Apr 03, 2019
Time
06:00 PM - 07:15 PM
Authors (listed alphabetically)

Previous Eposter
688 - Metformin Therapy is Associated with Reduced Risk of Vasculopathy and Cardiovascular Mortality after Heart Transplantation

Next Eposters
681 - Hypomagnesemia is Associated with New-Onset Diabetes Mellitus Following Heart Transplantation
706 - High Intra-Patient Variability of Echocardiographic Parameters is Associated with Heart Transplantation Outcomes: Report of a Real-World Experience
686 - Characteristics of Cardiopulmonary Exercise Tests in Heart Transplantation Patients: The Importance of Chronotropic Incompetence in Predicting Exercise Capacity
654 - Does Donor-Recipient Age Difference Matter in the Outcome of Heart Transplantation?
601 - Comparison of Endothelin-1 Level in Group I Pulmonary Hypertension vs. Group II Pulmonary Hypertension Both at Rest and at Peak Exercise
671 - Impact of Mobile Health in Heart Transplant Management: The mHeart Study
919 - Patient-Tailored Silicone Plug for HeartMate 3™ Left Ventricular Assist Device Explantation
812 - Point of Care Management of Perioperative Coagulopathy Reduces Blood Loss and Consumption of Blood Transfusion Products (Preliminary Results)
940 - Outcomes of Continuous-Flow Left Ventricular Assist Devices with No Antiplatelet Therapy: Systematic Review
1028 - Phenotypical Diversity of Airway Pathology in Chronic Pulmonary GvHD after Hematopoietic Stem Cell Transplantation